title: Physiological Responses of the Modified Shuttle Test in Adults With Cystic Fibrosis.
abstract: OBJECTIVE
  The modified shuttle test (MST) is increasingly used in clinical practice to assess functional capacity in patients with cystic fibrosis (CF). The purpose of this study was to evaluate the physiological responses of the MST in adults with CF as compared with the gold standard cardiopulmonary exercise test (CPET).
  
  
  METHODS
  Participants performed an MST and a CPET on a cycle ergometer in random order. Oxygen (O2) uptake ((Equation is included in full-text article.)O2), carbon dioxide (CO2) retention (end-tidal PCO2; PETCO2), minute ventilation, heart rate, and peripheral O2 saturation (SpO2) were continuously monitored. Whole blood lactate, dyspnea, and leg discomfort were recorded immediately after both exercises.
  
  
  RESULTS
  Twenty patients with CF (aged 33 ± 8 years; forced expiratory volume in 1 second = 48% ± 17%) completed both tests. Peak values for (Equation is included in full-text article.)O2 (27 ± 7 vs 24 ± 6 mL/kg/min), heart rate (169 ± 19 vs 163 ± 16 bpm), end PETCO2 (42 ± 7 vs 39 ± 8 mm Hg), and O2 desaturation (end SpO2, 86% ± 7% vs 90% ± 6%) were significantly higher during the MST than during the CPET (all Ps < .05). Leg discomfort and whole blood lactate were significantly higher after the CPET (both Ps < .05). Thirty-five percent and 40% of patients showed significant O2 desaturation and CO2 retention, respectively, during the MST, which was not detected during the CPET. A strong relationship was found between MST peak (Equation is included in full-text article.)O2 and body weight walking distance product (r = 0.90; P < .01).
  
  
  CONCLUSIONS
  The MST may provide a strong indicator of exercise tolerance in adults with CF as indicated by high peak (Equation is included in full-text article.)O2 values. In clinical practice, body weight walking distance should be considered as the primary outcome. This test is also better than cycle ergometry CPET for detecting O2 desaturation and CO2 retention, further emphasizing its clinical interest.
authors.affiliation: LAMHESS EA 6312, Universities of Toulon and Nice, Sophia-Antipolis, France (Drs Vallier, Mely, and Gruet); Tunisian Research Laboratory "Sport Performance Optimization," National Center of Medicine and Science in Sports, Tunis, Tunisia (Mr Rouissi); and Regional Cystic Fibrosis Unit (CRCM), Renée Sabran Hospital, Giens, France (Dr Mely).
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Vallier
authors.forename: Mehdi
authors.initials: M
authors.lastname: Rouissi
authors.forename: Laurent
authors.initials: L
authors.lastname: Mely
authors.forename: Mathieu
authors.initials: M
authors.lastname: Gruet
mesh_terms: D000328:Adult; D001835:Body Weight; D019296:Capnography; D002245:Carbon Dioxide / Q000378:metabolism; D003550:Cystic Fibrosis / Q000150:complications / Q000503:physiopathology*; D004417:Dyspnea / Q000209:etiology; D005260:Female; D006339:Heart Rate; D006801:Humans; D019344:Lactic Acid / Q000097:blood; D008297:Male; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D010313:Partial Pressure; D005082:Physical Exertion / Q000502:physiology*; D012123:Pulmonary Ventilation; D011897:Random Allocation; D000070857:Walk Test / Q000379:methods*; D055815:Young Adult
chemical_list: D002245:Carbon Dioxide; D019344:Lactic Acid; D010100:Oxygen